Skip to main content
. 2013 Feb 14;14:37. doi: 10.1186/1471-2369-14-37

Table 4.

Patients with normal baseline creatinine clearance (> 60 ml/min)

  Group 1 (n=15) Group 2 (n=85) p–value
Gender (m/f)
2/13
24/61
0.22
Age (yrs.)
58 (30–65)
52 (16–69)
0.39
BMI (kg/m2)
26.7 (23.2–36.0)
24.8 (16.0–36.2)
0.05
Hematocrit before TPL (%)
31.5 (15.3–40.0)
35.3 (21.7–49.6)
0.01
Platelets before TPL (103/μl)
83 (42–185)
92 (27–285)
0.32
MELD (corrected)
23 (6–31)
17 (7–33)
0.014
MELD (uncorrected)
21 (6–31)
12 (6–32)
0.13
CHILD (A/B/C in %)
23.1/30.8/46.1
35.4/41.8/22.8
0.20
Diabetes mellitus (%)
33.3%
16.8%
0.12
Admission from (Home/ward/ICU in %)
66.6/13.3/20.0
88.2/4.7/7.1
0.09
ASA class (II/III/IV in %)
6.7/53.3/40.0
11.8/61.2/27.0
0.55
Operating time (min)
390 (275–705)
355 (240–570)
0.11
Estimated intraoperative Blood loss (ml)
3000 (500–15000)
1000 (300–10000)
0.05
Marginal grafts (%)
46.7
35.3
0.40
Transfusion of – RBC (Unit)
2 (0–47)
3 (0–23)
0.36
- FFP (Unit)
12 (0–77)
12 (0–50)
0.62
- Platelets (Units)
1 (0–12)
0 (0–18)
0.37
- Fibrinogen (g)
2 (0–22)
0 (0–12)
0.08
Length of stay in ICU (days)
8 (3–54)
4 (2–31)
0.0003
Readmissions (%)
33.3
16.5
0.006
Incidence of Sepsis (%)
40.0
3.5
0.0001
Incidence of Respiratory Failure (w. reintubation) (%)
26.7
5.9
0.009
Reoperations (%)
40.0
10.6
0.001
Bilirubin peak (μmol/l)
157 (65–475)
87 (13–453)
0.003
ALT peak (U/l)
1625 (346–5147)
870 (133–7249)
0.02
AST peak (U/l) 1926 (389–10740) 1047 (114–13560) 0.02

Data expressed as median (range) or number of patients (percentage), TPL indicates transplantation, MELD model for end stage liver disease and ICU intensive care unit, respectively.